| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.31 | 6e-22 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.32 | 5e-12 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.25 | 6e-09 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.23 | 1e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.25 | 5e-06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |